63009-94-9 Usage
General Description
1-(methylamino)-3-phenylpropan-2-ol, also known as Methamphetamine, is a synthetic stimulant drug that affects the central nervous system. It is a powerful and highly addictive substance that can lead to severe health issues and addiction. Methamphetamine is typically manufactured in illegal laboratories and is commonly abused for its euphoric effects. The drug can cause a range of physical and psychological symptoms, including increased heart rate, elevated blood pressure, and insomnia. Chronic use of Methamphetamine can lead to long-term damage to the brain and body, as well as a range of mental health issues. It is classified as a Schedule II drug by the United States Drug Enforcement Administration due to its high potential for abuse and dependence.
Check Digit Verification of cas no
The CAS Registry Mumber 63009-94-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,0,0 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 63009-94:
(7*6)+(6*3)+(5*0)+(4*0)+(3*9)+(2*9)+(1*4)=109
109 % 10 = 9
So 63009-94-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO/c1-11-8-10(12)7-9-5-3-2-4-6-9/h2-6,10-12H,7-8H2,1H3
63009-94-9Relevant articles and documents
Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
-
Page/Page column 31, (2008/12/07)
Provided herein are Heterocyclic Compounds having the following structure: wherein R1, R2, X, Y and Z are as defined herein, compositions comprising an effective amount of a Heterocyclic Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heterocyclic Compound to a patient in need thereof.
Pyridoquinoxaline antivirals
-
, (2008/06/13)
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof wherein R1, R2 and R3 are as defined in the specification. The compounds are useful for the treatment of viral infections.
